Fu L - Search Results

1

The T393C polymorphism of GNAS1 as a predictor for chemotherapy sensitivity and survival in advanced non-small-cell lung cancer patients treated with gemcitabine plus platinum.

Xie FJ, Zhao P, Kou JY, Hong W, Fu L, Hu L, Hong D, Su D, Gao Y, Zhang YP. Xie FJ, et al. Among authors: fu l. Cancer Chemother Pharmacol. 2012 Jun;69(6):1443-8. doi: 10.1007/s00280-012-1849-3. Epub 2012 Feb 28. Cancer Chemother Pharmacol. 2012. PMID: 22371153

2

Characterization of tumor-suppressive function of SOX6 in human esophageal squamous cell carcinoma.

Qin YR, Tang H, Xie F, Liu H, Zhu Y, Ai J, Chen L, Li Y, Kwong DL, Fu L, Guan XY. Qin YR, et al. Among authors: fu l. Clin Cancer Res. 2011 Jan 1;17(1):46-55. doi: 10.1158/1078-0432.CCR-10-1155. Epub 2010 Nov 17. Clin Cancer Res. 2011. PMID: 21084391

3

Overexpression of GPR39 contributes to malignant development of human esophageal squamous cell carcinoma.

Xie F, Liu H, Zhu YH, Qin YR, Dai Y, Zeng T, Chen L, Nie C, Tang H, Li Y, Fu L, Guan XY. Xie F, et al. Among authors: fu l. BMC Cancer. 2011 Feb 25;11:86. doi: 10.1186/1471-2407-11-86. BMC Cancer. 2011. PMID: 21352519 Free PMC article.

4

Downregulation of the novel tumor suppressor DIRAS1 predicts poor prognosis in esophageal squamous cell carcinoma.

Zhu YH, Fu L, Chen L, Qin YR, Liu H, Xie F, Zeng T, Dong SS, Li J, Li Y, Dai Y, Xie D, Guan XY. Zhu YH, et al. Among authors: fu l. Cancer Res. 2013 Apr 1;73(7):2298-309. doi: 10.1158/0008-5472.CAN-12-2663. Epub 2013 Feb 22. Cancer Res. 2013. PMID: 23436800 Free article.

5

High-throughput loss-of-heterozygosity study of chromosome 3p in lung cancer using single-nucleotide polymorphism markers.

Tai AL, Mak W, Ng PK, Chua DT, Ng MY, Fu L, Chu KK, Fang Y, Qiang Song Y, Chen M, Zhang M, Sham PC, Guan XY. Tai AL, et al. Among authors: fu l. Cancer Res. 2006 Apr 15;66(8):4133-8. doi: 10.1158/0008-5472.CAN-05-2775. Cancer Res. 2006. PMID: 16618734

6

Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma.

Zhu C, Qin YR, Xie D, Chua DT, Fung JM, Chen L, Fu L, Hu L, Guan XY. Zhu C, et al. Among authors: fu l. Oncogene. 2009 Aug 6;28(31):2821-8. doi: 10.1038/onc.2009.137. Epub 2009 Jun 15. Oncogene. 2009. PMID: 19525977

7

Expression of Polo-Like Kinase 4(PLK4) in Breast Cancer and Its Response to Taxane-Based Neoadjuvant Chemotherapy.

Li Z, Dai K, Wang C, Song Y, Gu F, Liu F, Fu L. Li Z, et al. Among authors: fu l. J Cancer. 2016 Jun 6;7(9):1125-32. doi: 10.7150/jca.14307. eCollection 2016. J Cancer. 2016. PMID: 27326256 Free PMC article.

8

Identification of alpha-actinin 4 and 67 kDa laminin receptor as stage-specific markers in esophageal cancer via proteomic approaches.

Fu L, Qin YR, Xie D, Chow HY, Ngai SM, Kwong DL, Li Y, Guan XY. Fu L, et al. Cancer. 2007 Dec 15;110(12):2672-81. doi: 10.1002/cncr.23110. Cancer. 2007. PMID: 17960614 Free article.

9

Characterization of a candidate tumor suppressor gene uroplakin 1A in esophageal squamous cell carcinoma.

Kong KL, Kwong DL, Fu L, Chan TH, Chen L, Liu H, Li Y, Zhu YH, Bi J, Qin YR, Law SY, Guan XY. Kong KL, et al. Among authors: fu l. Cancer Res. 2010 Nov 1;70(21):8832-41. doi: 10.1158/0008-5472.CAN-10-0779. Epub 2010 Oct 26. Cancer Res. 2010. PMID: 20978196

10

Overexpression of matrix metalloproteinase 10 is associated with poor survival in patients with early stage of esophageal squamous cell carcinoma.

Liu H, Qin YR, Bi J, Guo A, Fu L, Guan XY. Liu H, et al. Among authors: fu l. Dis Esophagus. 2012 Sep-Oct;25(7):656-63. doi: 10.1111/j.1442-2050.2011.01284.x. Epub 2011 Nov 28. Dis Esophagus. 2012. PMID: 22121946

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,657 results

Search Page

Filters